Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

SP, ?4.8mm WN, SLA 12mm: medical device reports filed with FDA

750 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

750
device reports naming the brand
0% of all MAUDE reports · about 110 a year
60
reports, 12 months to August 2026
75 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 750 reports that name the brand "SP, ?4.8mm WN, SLA 12mm" (endosseous dental implant), received between September 2019 and August 2026; the manufacturer given most often on reports is Institut Straumann. Spellings of one product vary from report to report.

60 reports arrived in the 12 months to August 2026, down 20% from 75 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are loss of osseointegration (72.3%), failure to osseointegrate (28%) and unintended movement (0.3%). The patient problems coded most often are fibrosis, pain and tissue damage. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0918Sep 2021: 9Oct 2021: 8Nov 2021: 8Dec 2021: 62022Jan 2022: 13Feb 2022: 2Mar 2022: 8Apr 2022: 8May 2022: 10Jun 2022: 9Jul 2022: 15Aug 2022: 3Sep 2022: 9Oct 2022: 6Nov 2022: 5Dec 2022: 132023Jan 2023: 7Feb 2023: 7Mar 2023: 7Apr 2023: 9May 2023: 10Jun 2023: 14Jul 2023: 16Aug 2023: 13Sep 2023: 12Oct 2023: 13Nov 2023: 17Dec 2023: 62024Jan 2024: 5Feb 2024: 6Mar 2024: 5Apr 2024: 10May 2024: 4Jun 2024: 13Jul 2024: 9Aug 2024: 4Sep 2024: 9Oct 2024: 5Nov 2024: 3Dec 2024: 112025Jan 2025: 10Feb 2025: 2Mar 2025: 8Apr 2025: 0May 2025: 0Jun 2025: 18Jul 2025: 7Aug 2025: 2Sep 2025: 4Oct 2025: 3Nov 2025: 4Dec 2025: 82026Jan 2026: 3Feb 2026: 7Mar 2026: 4Apr 2026: 1May 2026: 3Jun 2026: 4Jul 2026: 14Aug 2026: 5

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0661312019: 9320192020: 12320202021: 11120212022: 10120222023: 13120232024: 8420242025: 6620252026: 412026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%750
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report91.2%684
Voluntary report0%0
User facility report0%0
Distributor report8.8%66
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Loss of osseointegration54272.3%22.4%
Failure to osseointegrate21028%62.8%
Unintended movement20.3%0%
Fracturea broken bone10.1%1.6%
Unstable10.1%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis21929.2%
Painpain, site not specified18324.4%
Tissue damage13518%
Inflammationinflammation10013.3%
Hemorrhage/blood loss/bleeding8811.7%
Swelling/ edema557.3%
Abscessa collection of pus293.9%
Fistula233.1%
Swellingswelling192.5%
Hyperresponsive to stimuli101.3%
Hypersensitivity/allergic reaction81.1%
Failure of implant60.8%
Increased sensitivity40.5%
Inadequate osseointegration30.4%
Numbnessnumbness10.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureSP, ?4.8mm WN, SLA 12mmProduct code DZEAll MAUDE reports
Reports7503,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer91.2%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about SP, ?4.8mm WN, SLA 12mm reports

How many FDA reports name SP, ?4.8mm WN, SLA 12mm?

750 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 60 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

loss of osseointegration (72.3%), failure to osseointegrate (28%), unintended movement (0.3%), fracture (0.1%) and unstable (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (91.2%) and distributor reports (8.8%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that SP, ?4.8mm WN, SLA 12mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.